19 results
Phosphate binders - quick reference chart of maximum daily dose. Most patients with CKD will require
maximum daily dose ... phosphate binding agents ... Generally, the initial dose ... phosphate levels and doses ... Hyperphosphatemia #Dose
Treatment of Stable Narrow-Complex Tachycardia
Regular Rhythm:
 • Attempt vagal maneuvers
 • Give adenosine 6 milligrams IV
milligrams IV push if does ... Repeat 12-milligram dose ... nodal blocking agents ... B-blockers) • Does ... management #cardiology #algorithm
ANGIOTENSIN II RECEPTOR ANTAGONIST (ARB) DOSING:
TOOL FOR SWITCHING BETWEEN AGENTS IN CANADA
The information provided is intended
) DOSING: TOOL ... SWITCHING BETWEEN AGENTS ... an alternative agent ... Doses should be ... Switching #Equivalent #Table
Potassium-Binding Agents to Treat Hyperkalemia
Sodium zirconium cyclosilicate (Lokelma):
 • Mechanism: Preferentially captures K in exchange for
Potassium-Binding Agents ... 10 g QD (adjust dose ... Usual maintenance dose ... g QD; increase dose ... #pharmacology #table
CA-Bridge Buprenorphine Hospital Quick Start Algorithm - Management of acute opiate withdrawal 
 - Any prescriber
If patient is stable ... sublingual (SL) are ... lower initial dose ... initial daily dose ... 7 days - May dose
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
a maintenance dose ... after the last dose ... or ticagrelor dose ... after the last dose ... after the last dose
Causes of Secondary Hypertension - Workup and Differential Diagnosis
Approach (when evaluation should be done):
1. Severe or
Causes of Secondary ... use of adequate doses ... antihypertensive agents ... with previously stable ... parenchymal disease: CKD
Inpatient Management of Opioid Use Disorder: Methadone vs Buprenorphine - Comparison Table

Some patients may decline buprenorphine
Buprenorphine - Comparison Table ... In these cases, ... Dosing usually begins ... formulation, the dose ... common side effects are
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Does the patient ... Does the patient ... event, follow ACC algorithm ... ACEi/ARBs - Hold ... revascularization does
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
Build a regimen using ... these injectable agents ... over injectable agents ... p-Aminosalicylic acid, High-dose ... #pharmacology #dosing